2 super growth stocks that could help you retire rich

Royston Wild discusses two stocks with stunning earnings potential.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

RISK WARNING: should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice. The Motley Fool believes in building wealth through long-term investing and so we do not promote or encourage high-risk activities including day trading, CFDs, spread betting, cryptocurrencies, and forex. Where we promote an affiliate partner’s brokerage products, these are focused on the trading of readily releasable securities.

For those seeking spectacular earnings growth in the near term and beyond, I reckon investors could do a lot worse than check out Spirent Communications (LSE: SPT).

The Crawley firm has seen its share price accelerate as speculation that it could be a takeover target has hit fever pitch. Indeed, Spirent hit record tops above 125p per share just today after analysts at Citi lauded the quality of the tech play’s business and favourable exposure to end markets.

And it is easy to see why Spirent — which provides testing services for broadband and 4G networks — could attract advances from potential suitors.

While Spirent saw revenues increasing 4% during January-March, to $106.4m, sales at its Networks & Security arm soared 23%, crushing expectations as demand for its high-speed Ethernet products grew. And the terrific reception to recently-launched offers like CyberFlood and SecurityLabs suggests that sales should keep rocketing higher.

City brokers expect Spirent to wave goodbye to the earnings volatility of recent years and print a 29% earnings advance in 2017, following on from last year’s more modest 6% rise. And a further 16% increase is chalked in for 2018.

And in my opinion, Spirent provides excellent value for money based on these projections. Sure, a forward P/E ratio of 23.7 times may sail above the widely-regarded value yardstick of 15 times. But a PEG readout of 0.8 (below the bargain benchmark of one) actually suggests the tech titan is priced attractively relative to its growth prospects.

I reckon Spirent could prove a wise long-term investment as global telecommunications investment steadily grows.

Chemical fix

Like Spirent, the number crunchers also expect Treatt (LSE: TET) to enjoy breakneck bottom-line growth in the years ahead.

The chemicals play — which produces flavour, fragrance and cosmetic ingredients — announced this week that revenues climbed 27% during October-March, to £51.8m, a result that pushed adjusted pre-tax profit 63% higher to £5.5m.

And in a promising update on recent trading, chief executive Daemmon Reeve commented that “the strong performance… has continued into the third quarter with group order books remaining materially higher than this time last year as the benefit of some significant new business wins continues to show through.”

Following a similarly-spectacular February trading statement, Treatt has seen its share price scream 63% higher in 2017 and top out at a new all-time peak around 420p per share just today. However, I reckon the business still provides very-decent value at current prices.

In the year to September 2017 Treatt is predicted to churn out a 44% earnings advance, and to follow this up with a 5% rise in fiscal 2018.

The Bury St Edmunds business deals on a forward P/E ratio of 22.6 times, as a result, or a mere PEG reading of 0.5 times. Given the prospect of earnings upgrades as sales boom across the globe (sales in China exploded 43% in the half year, for example), I reckon Treatt is a great growth selection at current prices.

RISK WARNING: should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice. The Motley Fool believes in building wealth through long-term investing and so we do not promote or encourage high-risk activities including day trading, CFDs, spread betting, cryptocurrencies, and forex. Where we promote an affiliate partner’s brokerage products, these are focused on the trading of readily releasable securities.

Royston Wild has no position in any shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

Publish Test

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut…

Read more »

Investing Articles

JP P-Press Update Test

Read more »

Investing Articles

JP Test as Author

Test content.

Read more »

Investing Articles

KM Test Post 2

Read more »

Investing Articles

JP Test PP Status

Test content. Test headline

Read more »

Investing Articles

KM Test Post

This is my content.

Read more »

Investing Articles

JP Tag Test

Read more »

Investing Articles

Testing testing one two three

Sample paragraph here, testing, test duplicate

Read more »